March is #WomensHistoryMonth! Let’s celebrate the incredible achievements, resilience, and contributions of women throughout history and today. We interviewed Jennifer Tousignant, our Chief Legal Officer, who shared what Women’s History Month means to her. #WHM #EmpowerWomen #TeamViridian
Viridian Therapeutics, Inc.
Biotechnology Research
Waltham, Massachusetts 13,688 followers
Framing the future of autoimmune diseases
About us
Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is to advance VRDN-001 as a potential best-in-class intravenous therapy followed by VRDN-003 as a potential first- and best-in-class subcutaneous therapy for the treatment of TED. In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.
- Website
-
http://www.viridiantherapeutics.com
External link for Viridian Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Public Company
- Founded
- 2007
Locations
-
Primary
203 Crescent St
Building 17, Suite 102B
Waltham, Massachusetts 02453, US
-
6200 Lookout Road
Boulder, Colorado 80301, US
Employees at Viridian Therapeutics, Inc.
-
Thomas Martin
Commercial Operations | Life Sciences | Biotechnology | Go-to-Market Planning | Analytics | Brand Planning | Forecasting | Strategy | Program…
-
Steve Engen
CEO, Renexes LLC
-
Mark Howansky
Vice President of Device Development and Commercialization at Viridian Therapeutics, Inc.
-
Jon Sarno
Senior Director, Medical Device Quality at Viridian Therapeutics
Updates
-
March is Autoimmune Awareness Month! We had a chance to connect with Colleen Kmiecik, Director of Marketing and Communications at the Autoimmune Association, to learn more about the Association’s efforts to recognize the millions impacted by autoimmune conditions, amplify their voices, and to advocate for greater understanding, research, and support for those affected. 📖 Read more of what Colleen shared with our team over on the Viridian Community Corner, here > https://lnkd.in/eEhSRyRg #AutoimmuneAwarenessMonth #Community #PatientVoice #Awareness #Autoimmune #AutoimmuneVoices #TED #ThyroidEyeDisease
-
-
Earlier this week at the NANOS - North American Neuro-Ophthalmology Society 2025 Annual Meeting we presented, for the first time, learnings from the ElevaTED survey. Thank you to the over 200 people living with thyroid eye disease (TED) who participated and shared how the impacts of this autoimmune condition extend beyond commonly associated symptoms. Your perspectives and experiences provide an invaluable understanding of TED that are vital to ensuring your needs and priorities are accurately reflected in the development of new medicine and the shaping of healthcare systems. View the poster on our website, here: https://lnkd.in/ekf_M-SY We, along with our collaborators Dr. Abrams, Dr. Cockerham, and Christine Gustafson, look forward to sharing more from the ElevaTED survey at future congresses. #NANOS2025 #NANOS #TED #AutoimmuneAwarenessMonth #ThyroidEyeDisease #Vision #GravesDisease #PatientVoice
-
-
Did you know that there are more than 100 autoimmune conditions? As part of Autoimmune Awareness Month, we are helping to shine a spotlight on thyroid eye disease (TED) by amplifying the voices of those directly impacted by this autoimmune condition. TED is an autoimmune condition characterized by inflammation, growth, and damage to tissues around and behind the eyes. Thank you, Christine, Frank, and Layla, for sharing your personal stories for all of us to learn from. Visit https://lnkd.in/eEhSRyRg for more. #AutoimmuneAwarenessMonth #Advocacy #Community #PatientVoice #DKY #CarePartnerVoice #TED #ThyroidEyeDisease #GravesDisease #Autoimmune
-
Viridian is proud to sponsor NANOS - North American Neuro-Ophthalmology Society 2025 Annual Meeting from March 15-20, and present data from our ElevaTED survey and ongoing thyroid eye disease (TED) clinical development program. Visit our website for more information: https://lnkd.in/gjGChAEu #ThryoidEyeDisease #TED #PatientVoice
-
We Are Hiring! We have multiple openings across many of our functions – be part of an inclusive and growing team at Viridian! Current openings can be viewed on our Careers Page #TeamViridian #WeAreHiring
-
-
As a company focused on engineering and developing potential next-generation medicines for people living with autoimmune and rare diseases, we are proud to join the community in raising recognition and hope in March for Autoimmune Awareness Month. This nationwide movement of awareness aims to advance education, research, and understanding. To learn how you can help get involved, visit the Autoimmune Association website, here > https://autoimmune.org/. #AutoimmuneAwarenessMonth #Advocacy #Awareness #Community #TED #ThyroidEyeDisease
-
-
Today, as a proud sponsor of Rare Disease Day through the National Organization for Rare Disorders, we Show Our Stripes and Colors to raise awareness and advocate for those living with rare diseases and their loved ones. With more than 10,000 rare conditions, everyone likely knows someone impacted by a rare disease. For Rare Disease Day 2025, we encourage our followers to learn about this especially rare day and the vast yet diverse rare community by connecting with a patient advocacy organization, https://www.viridiantherapeutics. com/patients/. #RareDiseaseDay #Rare #ShowYourStripes #Advocacy #Awareness #Community #RareDisease #ShowYourStripes #RDD2025
-
Today, we reported Q4 and Full Year 2024 #earnings and updates on our recent progress. Read more here: https://lnkd.in/eWJX69tE
-
-
Viridian looks forward to connecting with physicians who treat thyroid eye disease (TED) at the UCLA Health International TED Masters Seminar & Workshop this Friday and Saturday, February 21-22, at the Stein Eye Institute in Los Angeles, California. Information on Viridian’s TED clinical development program will be featured at our exhibit, and on February 22nd at a presentation by Dr. Steve Leibowitz. #ThyroidEyeDisease #TED #GravesDisease #Opthomology #Vision
-